By Dave Andrusko On Monday, the FDA sent warning letters to two online entities for introducing “Misbranded and Unapproved New Drugs into Interstate Commerce,” specifically mifepristone and misoprostol, the two drugs that make up the “RU-486”abortion technique. AidAccess.org and Rablon were told to immediately stop selling unapproved versions of the drugs and to “respond to …Continue reading "FDA sends warning letters to two entities selling mislabeled and unapproved abortion drugs over the Internet"
By Dave Andrusko Editor’s note. If you want to peruse stories all day long, go directly to nationalrighttolifenews.org and/or follow me on Twitter at twitter.com/daveha Since pro-lifers have no insiders inside the Guttmacher Institute, we can only speculate why it takes forever and a day (three years or so) for this pro-abortion think-tank to update …Continue reading "Texas Planned Parenthood says 4-fold increase in chemical abortions since FDA relaxed protocol"
By Dave Andrusko If you click here, you can read the entire letter sent by Rep. Chris Smith (R-NJ) and Senator James Lankford (R-OK), joined by 73 of their colleagues, to Dr. Robert M. Califf, M.D., the FDA’s Commissioner, “requesting information about the agency’s recent decision to change its policies regarding the abortion drug mifepristone.” …Continue reading "Members of House and Senate ask for documents behind FDA change in FDA protocol"
Editor’s note. The following letter was sent to the Commissioner of the FDA by Rep. Chris Smith (R-NJ) and Senator James Lankford (R-OK), joined by 73 of their colleagues. April 25, 2016 Dr. Robert M. Califf, M.D. Commissioner Food and Drug Administration (FDA) 10903 New Hampshire Ave Silver Spring, MD 20993 Dear Commissioner Califf, We …Continue reading "In letter Members of House and Senate voice deep disappointment that FDA loosened standards for use of RU-486"
WASHINGTON–Cardinal Timothy Dolan, archbishop of New York and chair of the U.S. Conference of Catholic Bishops’ Committee on Pro-Life Activities responded to new guidelines issued by the Food and Drug Administration (FDA) for the abortion drug, RU-486. “The FDA has irresponsibly loosened its guidelines for the dangerous abortion drug RU-486 expanding its use an additional …Continue reading "Cardinal Dolan Calls New FDA Abortion Drug Guidelines ‘Irresponsible,’ Offers Assistance to Pregnant Women"
By Dave Andrusko There was so much coverage yesterday of Donald Trump’s comment about “punishing” women who have aborted (a position he later reversed) that perhaps not enough attention was paid to the gift the FDA gave to the Abortion Industry in general, Planned Parenthood in particular. Both Dr. Randall K. O’Bannon, Ph.D., NRL Director …Continue reading "Unanswered questions in light of FDA changing its RU-486 protocol"
By Dave Andrusko Dr. Randall K. O’Bannon, Ph.D., NRL Director of Education & Research, knows as much as anyone in the pro-life community about the two-drug abortion technique, RU-486. That’s why before you read these remarks, please read his story responding the Food and Drug Administration’s decision today to relax safety standards and modified the …Continue reading "FDA greases the skids for greater use of chemical abortions"
By Randall K. O’Bannon Planned Parenthood, America’s biggest and most lucrative abortion chain, is still telling women that RU486 chemical abortions are “highly safe, highly effective” (NPR, 1/24/11). The National Abortion Federation declares that chemical abortions “have an excellent safety profile” (NAF, Factsheet, “Safety of Abortion,” 12/06). Danco, the U.S. distributor of the abortion pill, …Continue reading "What the FDA Website Says about RU486"
By Dave Andrusko “These latest deaths tell us that, despite all the investigations, all the warnings, all the assurances, women taking RU486 and its accompanying prostaglandin misoprostol are still dying.” — Dr. Randall K. O’Bannon, NRL Director of Education, from “The Story Behind Two New RU486 Patient Deaths,” October 14, 2010. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ National Right …Continue reading "FDA Update Reveals 14 Deaths from RU486, 2,209 “Adverse Events”"